Abstract

A urine-based screening technique for Lyme disease (LD) was developed in this research. The screen is based on Raman spectroscopy, iterative smoothing-splines with root error adjustment (ISREA) spectral baselining, and chemometric analysis using Rametrix software. Raman spectra of urine from 30 patients with positive serologic tests (including the US Centers for Disease Control [CDC] two-tier standard) for LD were compared against subsets of our database of urine spectra from 235 healthy human volunteers, 362 end-stage kidney disease (ESKD) patients, and 17 patients with active or remissive bladder cancer (BCA). We found statistical differences (p < 0.001) between urine scans of healthy volunteers and LD-positive patients. We also found a unique LD molecular signature in urine involving 112 Raman shifts (31 major Raman shifts) with significant differences from urine of healthy individuals. We were able to distinguish the LD molecular signature as statistically different (p < 0.001) from the molecular signatures of ESKD and BCA. When comparing LD-positive patients against healthy volunteers, the Rametrix-based urine screen performed with 86.7% for overall accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), respectively. When considering patients with ESKD and BCA in the LD-negative group, these values were 88.7% (accuracy), 83.3% (sensitivity), 91.0% (specificity), 80.7% (PPV), and 92.4% (NPV). Additional advantages to the Raman-based urine screen include that it is rapid (minutes per analysis), is minimally invasive, requires no chemical labeling, uses a low-profile, off-the-shelf spectrometer, and is inexpensive relative to other available LD tests.

© 2022 The Author(s)

Demonstrating the application of Raman spectroscopy together with chemometric technique for screening of asthma disease

Rahat Ullah, Saranjam Khan, Fizah Farman, Muhammad Bilal, Christoph Krafft, and Shaheen Shahzad
Biomed. Opt. Express 10(2) 600-609 (2019)

Rapid and label-free urine test based on surface-enhanced Raman spectroscopy for the non-invasive detection of colorectal cancer at different stages

Jinyong Lin, Zongwei Huang, Xueliang Lin, Qiong Wu, Kerun Quan, Yanming Cheng, Mingzhi Zheng, Jiaying Xu, Yitao Dai, Hejin Qiu, Duo Lin, and Shangyuan Feng
Biomed. Opt. Express 11(12) 7109-7119 (2020)

Chemical concentration measurement in blood serum and urine samples using liquid-core optical fiber Raman spectroscopy

Dahu Qi and Andrew J. Berger
Appl. Opt. 46(10) 1726-1734 (2007)

Noninvasive liver diseases detection based on serum surface enhanced Raman spectroscopy and statistical analysis

Xiaozhou Li, Tianyue Yang, Siqi Li, Lili Jin, Deli Wang, Dagang Guan, and Jianhua Ding
Opt. Express 23(14) 18361-18372 (2015)

Fluorometric optical sensor arrays for the detection of urinary bladder cancer specific volatile organic compounds in the urine of patients with frank hematuria: a prospective case-control study

Simian Zhu, Zhihong Huang, and Ghulam Nabi
Biomed. Opt. Express 11(2) 1175-1185 (2020)